Brief: Aequus Extends And Enhances Commercial Agreement To Promote Vistitan In Canada

Aequus Pharmaceuticals

16/07/2018 13:59

July 16 (Reuters) - Aequus Pharmaceuticals Inc  AQS.V :
    * AEQUUS EXTENDS AND ENHANCES COMMERCIAL AGREEMENT TO
PROMOTE
VISTITAN IN CANADA
    * AEQUUS PHARMACEUTICALS INC -  AGREED TO NEW TERMS FOR ITS
PROMOTIONAL SERVICE AGREEMENT WITH SANDOZ ON VISTITAN
    * AEQUUS PHARMACEUTICALS INC - AEQUUS & SANDOZ SPLIT
REVENUES
BASED UPON AN AGREED TO TIERED STRUCTURE OVER TERM
    * AEQUUS PHARMACEUTICALS INC - TERM HAS BEEN EXTENDED TO
JUNE
2021, WITH OPTION FOR RENEWAL IF MUTUALLY AGREED TO
    * AEQUUS - WITH AMENDMENT, REVENUE SPLITS OF VISTITAN AS OF
2019
TO INCREASE FROM ORIGINAL TIERING SCHEDULE BY AN ADDITIONAL 7%
OF NET PRODUCT SALES
    * AEQUUS - ALSO ON MILESTONES FULFILLMENT, REVENUE SPLITS OF
VISTITAN AS OF 2019 TO INCREASE FROM ORIGINAL TIERING SCHEDULE
UP TO ADDITIONAL 12%

Source text for Eikon:  ID:nGNX7z3dd9 
Further company coverage:  AQS.V 

 ((Reuters.Briefs@thomsonreuters.com;))